S. Krähenbühl

845 total citations
21 papers, 592 citations indexed

About

S. Krähenbühl is a scholar working on Oncology, Pharmacology and Epidemiology. According to data from OpenAlex, S. Krähenbühl has authored 21 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Pharmacology and 4 papers in Epidemiology. Recurrent topics in S. Krähenbühl's work include Drug-Induced Hepatotoxicity and Protection (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Liver Disease and Transplantation (4 papers). S. Krähenbühl is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Liver Disease and Transplantation (4 papers). S. Krähenbühl collaborates with scholars based in Switzerland, Germany and Netherlands. S. Krähenbühl's co-authors include Christine Talos, Bernhard H. Lauterburg, L. Krähenbühl, Jürg Reichen, Mehdi Ouaïssi, Urs Giger, Sven Fischer, Arthur Zimmermann, Jürg Reichen and Stefan Russmann and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

S. Krähenbühl

20 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Krähenbühl Switzerland	12	187	179	157	157	111	21	592
Shigeyuki Nagata Japan	16	200 1.1×	118 0.7×	193 1.2×	205 1.3×	137 1.2×	59	627
Yoshiro Taki Japan	15	362 1.9×	145 0.8×	296 1.9×	276 1.8×	82 0.7×	52	751
Tetsuya Ito Japan	17	248 1.3×	165 0.9×	191 1.2×	228 1.5×	159 1.4×	59	758
Jan Pfeiffenberger Germany	17	220 1.2×	127 0.7×	171 1.1×	150 1.0×	57 0.5×	50	1.0k
P. Sabín Spain	14	173 0.9×	80 0.4×	247 1.6×	257 1.6×	116 1.0×	30	752
Wissam Bleibel United States	12	148 0.8×	101 0.6×	94 0.6×	109 0.7×	92 0.8×	25	458
Van Thiel Dh United States	13	129 0.7×	88 0.5×	196 1.2×	150 1.0×	30 0.3×	45	538
Murat Saruç Türkiye	15	255 1.4×	125 0.7×	58 0.4×	100 0.6×	70 0.6×	45	604
Masanori Furukawa Japan	14	152 0.8×	103 0.6×	190 1.2×	308 2.0×	61 0.5×	39	663
P G Wheeler United Kingdom	10	213 1.1×	108 0.6×	242 1.5×	171 1.1×	137 1.2×	14	538

Countries citing papers authored by S. Krähenbühl

Since Specialization

Citations

This map shows the geographic impact of S. Krähenbühl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Krähenbühl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Krähenbühl more than expected).

Fields of papers citing papers by S. Krähenbühl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Krähenbühl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Krähenbühl. The network helps show where S. Krähenbühl may publish in the future.

Co-authorship network of co-authors of S. Krähenbühl

This figure shows the co-authorship network connecting the top 25 collaborators of S. Krähenbühl. A scholar is included among the top collaborators of S. Krähenbühl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Krähenbühl. S. Krähenbühl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joerger, Markus, Manuel Haschke, S. Krähenbühl, et al.. (2017). Prognostic impact of drug interactions in patients with advanced cancer. Annals of Oncology. 28. v498–v498. 1 indexed citations

Gregoriano, Claudia, Alessandro Ceschi, Christine Rauber‐Lüthy, et al.. (2013). PP231—Acute human toxicity of thiopurines, mycophenolate and sirolimus. Clinical Therapeutics. 35(8). e91–e92.

Joerger, Markus, A. D. R. Huitema, S. Krähenbühl, et al.. (2010). Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial. British Journal of Cancer. 102(4). 673–677. 70 indexed citations

Giger, Urs, et al.. (2010). Bile duct injury and use of cholangiography during laparoscopic cholecystectomy. British journal of surgery. 98(3). 391–396. 83 indexed citations

Bodmer, Mark, Patrizia Amico, M. J. Mihatsch, et al.. (2007). Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient. Nephrology Dialysis Transplantation. 22(8). 2366–2370. 33 indexed citations

Kaufmann, Priska, et al.. (2004). 78 Mechanisms of benzarone and benzbromarone induced hepatic toxicity. Journal of Hepatology. 40. 27–28. 6 indexed citations

Krähenbühl, S. & Gerhard Eich. (2002). Neue Methoden in Diagnostik und Therapie: Linezolid. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 2 indexed citations

Russmann, Stefan, et al.. (2001). Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. European Journal of Gastroenterology & Hepatology. 13(3). 287–290. 64 indexed citations

Helbling, Arthur, et al.. (2001). Cholangiopathy after short‐term administration of piperacillin and imipenem/cilastatin. Liver International. 21(3). 213–216. 4 indexed citations

10.

Stucki, Gerold, et al.. (2000). Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis. Lara D. Veeken. 39(3). 293–298. 31 indexed citations

11.

Krähenbühl, L., et al.. (2000). Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced liver cirrhosis. Journal of Hepatology. 33(2). 216–223. 24 indexed citations

12.

Seiler, Christian, et al.. (2000). Effect of cirrhosis on hepatic glycogen metabolism in humans. Journal of Hepatology. 32. 123–123. 1 indexed citations

13.

Krähenbühl, S.. (1998). [Adjusting dosage of drugs in patients with kidney or liver failure].. PubMed. 128(6). 189–94. 1 indexed citations

14.

Kronenberg, Andreas, et al.. (1998). [Severe hepatocellular damage after administration of paracetamol and chlorzoxazone in therapeutic dosage].. PubMed. 87(41). 1356–60. 3 indexed citations

15.

Krähenbühl, L., Christine Talos, Jürg Reichen, & S. Krähenbühl. (1996). Progressive Decrease in Tissue Glycogen Content in Rats With Long–Term Cholestasis. Hepatology. 24(4). 902–907. 28 indexed citations

16.

Krähenbühl, S., et al.. (1995). Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology. 22(2). 607–612. 121 indexed citations

17.

Souček, Miroslav, et al.. (1995). Disappearance of a large mediastinal pseudocyst in a patient with chronic alcoholic pancreatitis after total parenteral nutrition.. PubMed. 7(4). 369–71. 18 indexed citations

18.

Krähenbühl, S., et al.. (1994). Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: Dose-response study in isolated rat liver mitochondria. Hepatology. 20(6). 1595–1601. 59 indexed citations

19.

Krähenbühl, S. & Jürg Reichen. (1993). Decreased hepatic glucose production in rats with carbon tetrachloride-induced cirrhosis. Journal of Hepatology. 19(1). 64–70. 23 indexed citations

20.

Krähenbühl, S., et al.. (1989). Effect of secretin on bile formation in rats with cirrhosis of the liver: Structure-function relationship. Gastroenterology. 97(4). 950–957. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact